.jpg "SURPASS-4: Tirzepatide Reduces A1C, Body Weight in Type 2 Diabetes")
By Linda Carroll (Reuters Health) - Minority children in England were less likely to be tested for COVID-19, but more likely to be positive when tested, than white children, researchers there report. Read More »
By Julie Steenhuysen (Reuters) - The U.S. Food and Drug Administration on Tuesday released a sweeping series of memos revealing a clear struggle within the agency ahead of its controversial decision Read More »
By Lisa Rapaport (Reuters Health) - Many U.S. patients taking levothyroxine started treatment when they had subclinical hypothyroidism and only mildly increased thyrotropin levels, a recent study Read More »
By Lisa Rapaport (Reuters Health) - Women who consume three or more drinks a week during the luteal phase of their menstrual cycle or more than six weekly drinks during the ovulatory window may Read More »
By Marilynn Larkin NEW YORK (Reuters Health) - In patients hospitalized with COVID-19 and elevated D-dimer concentrations, therapeutic dosing of oral anticoagulants did not improve outcomes compared Read More »
By Linda Carroll (Reuters Health) - SARS-CoV-2 breakthrough infections were rare in a cohort of fully vaccinated California healthcare workers and the Epsilon variant of concern was no more likely Read More »
By Marilynn Larkin NEW YORK (Reuters Health) - Concentrations of neurofilament light chain (NFL), a marker of neuroaxonal injury, predicted the extent of neuronal damage in a cohort of patients Read More »
By Ronnie Cohen (Reuters Health) - More than half the cosmetics sold in the United States and Canada have high levels of PFAS, chemicals associated with increased cancer risks, decreased vaccine Read More »
